ت:    25332330
نقال: 90094424
2:00 الى 6:00 مساءا (أيام الإسبوع)
السبت 10:30 ص-1:30 م. الجمعة عطلة

NIH ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development

01/07/2020

The authors conclude that large, randomized, controlled trials of SARS-CoV-2 are the fastest and most effective path forward for establishing vaccine safety and efficacy.

Read More